Literature DB >> 22918529

Critical illness myopathy.

Nicola Latronico1, Giuliano Tomelleri, Massimiliano Filosto.   

Abstract

PURPOSE OF REVIEW: To describe the incidence, major risk factors, and the clinical, electrophysiological, and histological features of critical illness myopathy (CIM). Major pathogenetic mechanisms and long-term consequences of CIM are also reviewed. RECENT
FINDINGS: CIM is frequently associated with critical illness polyneuropathy (CIP), and may have a relevant impact on patients' outcome. CIM has an earlier onset than CIP, and recovery is faster. Loss of myosin filaments on muscle biopsy is important to diagnose CIM, and has a good prognosis. Critical illness, use of steroids, and immobility concur in causing CIM.
SUMMARY: A rationale diagnostic approach to CIM using clinical, electrophysiological, and muscle biopsy investigations is important to plan adequate therapy and to predict recovery.

Entities:  

Mesh:

Year:  2012        PMID: 22918529     DOI: 10.1097/BOR.0b013e3283588d2f

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  10 in total

1.  Glucocorticoid-induced myopathy in the intensive care unit.

Authors:  Heidi Shil Eddelien; Henrik Westy Hoffmeyer; Eva Løbner Lund; Anne Øberg Lauritsen
Journal:  BMJ Case Rep       Date:  2015-05-24

Review 2.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

3.  Multimodal assessment of intensive care unit-acquired weakness in severe stroke patients.

Authors:  Berin Inan; Can Ebru Bekircan-Kurt; Zeynep Ergul-Ulger; Merve Yilmaz; Zeliha Gunnur Dikmen; Ethem Murat Arsava; Mehmet Akif Topcuoglu; Omur Caglar; Merve Basol; Ergun Karaagaoglu; Sevim Erdem-Ozdamar; Ersin Tan; Cagri Mesut Temucin
Journal:  Acta Neurol Belg       Date:  2022-07-06       Impact factor: 2.471

4.  Therapeutic Potential of Electromyostimulation (EMS) in Critically Ill Patients-A Systematic Review.

Authors:  Maryam Balke; Marc Teschler; Hendrik Schäfer; Pantea Pape; Frank C Mooren; Boris Schmitz
Journal:  Front Physiol       Date:  2022-05-09       Impact factor: 4.755

Review 5.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

6.  Transcriptional profiling reveals extraordinary diversity among skeletal muscle tissues.

Authors:  Erin E Terry; Xiping Zhang; Christy Hoffmann; Laura D Hughes; Scott A Lewis; Jiajia Li; Matthew J Wallace; Lance A Riley; Collin M Douglas; Miguel A Gutierrez-Monreal; Nicholas F Lahens; Ming C Gong; Francisco Andrade; Karyn A Esser; Michael E Hughes
Journal:  Elife       Date:  2018-05-29       Impact factor: 8.140

Review 7.  Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19.

Authors:  Madu N Soares; Moritz Eggelbusch; Elie Naddaf; Karin H L Gerrits; Marike van der Schaaf; Bram van den Borst; W Joost Wiersinga; Michele van Vugt; Peter J M Weijs; Andrew J Murray; Rob C I Wüst
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-07       Impact factor: 12.910

8.  Masseter muscle myofibrillar protein synthesis and degradation in an experimental critical illness myopathy model.

Authors:  Hazem Akkad; Rebeca Corpeno; Lars Larsson
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

9.  Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial.

Authors:  Richard Brunner; Walter Rinner; Christine Haberler; Reinhard Kitzberger; Thomas Sycha; Harald Herkner; Joanna Warszawska; Christian Madl; Ulrike Holzinger
Journal:  Crit Care       Date:  2013-10-02       Impact factor: 9.097

10.  Impaired Ca(2+) release contributes to muscle weakness in a rat model of critical illness myopathy.

Authors:  Monica Llano-Diez; Arthur J Cheng; William Jonsson; Niklas Ivarsson; Håkan Westerblad; Vic Sun; Nicola Cacciani; Lars Larsson; Joseph Bruton
Journal:  Crit Care       Date:  2016-08-10       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.